Eden
Eden now advertises compounded semaglutide and tirzepatide at recurring monthly prices without a separate membership fee; its FDA warning history remains relevant.
- Semaglutide
$99/mo
No separate membership fee advertised.
Same recurring rate; no long-term contract advertised.
Full price details
$99/month for compounded semaglutide on the current GLP-1 program; no separate membership fee or long-term contract advertised
- Tirzepatide
$129/mo
No separate membership fee advertised.
Same recurring rate; no long-term contract advertised.
Full price details
$129/month for compounded tirzepatide on the current GLP-1 program; no separate membership fee or long-term contract advertised
- Coverage
- All 50 states
FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.